Additional file 3 of IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation

Additional file 3: Table 1. Clinical-pathological features and Tumor mutational burden of 39 GBMs enriched in giant cells. Cases are sorted by ID number. Table 2: List of somatic and germline mutations identified in all samples. Table 3. MMR mutations, MMR immunohistochemistry, MSI and TMB in 39 giant cell enriched GBMs. Cases are arranged by TMB.

附加文件3：表1。39例富含巨细胞的胶质母细胞瘤（Glioblastoma, GBM）的临床病理特征与肿瘤突变负荷（Tumor mutational burden, TMB），病例按ID编号排序。表2：所有样本中鉴定出的体细胞突变与生殖系突变清单。表3：39例富含巨细胞的胶质母细胞瘤的错配修复（Mismatch Repair, MMR）突变、错配修复免疫组化结果、微卫星不稳定性（Microsatellite Instability, MSI）及肿瘤突变负荷情况，病例按肿瘤突变负荷排序。